Steven Earl Freeman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 764 Saco Lowell Rd, Easley, SC 29640 Phone: 864-855-5525 Fax: 864-855-5440 |
David Olugbenga Biobaku, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-442-7200 Fax: 864-442-8279 |
William Major Anderson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 704 N A St, Easley, SC 29640 Phone: 864-859-4089 |
Clay Carter Evans, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Fleetwood Dr, Easley, SC 29640 Phone: 864-522-8603 |
News Archive
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, responded to today's announcement by the Obama Administration that it will allocate $30 million in funding to address the national AIDS Drug Assistance Program crisis that has left 3,000 Americans on waiting lists to receive lifesaving AIDS medications by saying "Thank you, but it is not nearly enough."
Researchers at The University of Texas M. D. Anderson Cancer Center and the National Cancer Institute have found that an experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma, even though prior therapy had eliminated virtually all of the B cells thought necessary to mount such a defense.
Supporting patient autonomy in healthcare leads to positive health outcomes, suggesting that self-determination theories should become the foundation for developing interventions in healthcare promotion, say UK researchers.
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
Natural Alternatives International, Inc., a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.1 million or $0.15 per diluted share on net sales of $17.4 million for the quarter ended March 31, 2012.
› Verified 5 days ago